Medical Technology

SHERIDAN, WYOMING – July 25, 2025 – Philips has secured FDA 510(k) clearance for its next-generation UroNav platform, reinforcing the company’s leadership in image-guided interventions for prostate cancer. The upgraded UroNav 2.0 system is designed to unify MR/ultrasound fusion imaging with advanced workflow integration, helping clinicians deliver more accurate, less invasive, and highly personalized focal therapies.

SHERIDAN, WYOMING – July 25, 2025 – Philips and Radboud university medical center (Radboudumc) are conducting one of the first large-scale studies to explore the impact of prolonged physical activity on atrial fibrillation, leveraging wearable monitoring technology during the 4Days Marches in the Netherlands. The collaboration combines clinical expertise with cutting-edge sensor technology to better understand how exercise influences this widespread heart rhythm disorder.

Continuous Monitoring for Deeper Insight into Atrial Fibrillation

SHERIDAN, WYOMING – July 25, 2025 – Royal Philips has initiated a major international clinical trial to evaluate its new ultra-low X-ray dose technology designed for coronary procedures. The RADIQAL trial aims to generate real-world evidence that the innovation can significantly reduce radiation exposure for both patients and clinical staff without compromising the image quality or procedural performance critical to interventional cardiology.

Strategic push for radiation dose reduction in cardiology

SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. has announced a significant leadership transition, positioning its executive team for continued strategic growth in the musculoskeletal technology sector. Effective July 18, 2025, Keith Pfeil assumed the role of President and Chief Executive Officer, succeeding Daniel Scavilla, who stepped down to pursue another opportunity. Additionally, Kyle Kline was appointed Senior Vice President and Chief Financial Officer.

Leadership Shifts Focused on Strategic Growth

SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. has scheduled the announcement of its financial results for the second quarter ended June 30, 2025, for Thursday, August 7, 2025, after market close. The musculoskeletal technology leader will publish the earnings release on its investor relations website at www.investors.globusmedical.com.

Investor Call Scheduled for August 7

SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. has announced the expansion of its Excelsius™ navigation capabilities with the introduction of DuraPro™, a next-generation oscillating system designed to enhance surgical precision while safeguarding delicate tissue. As part of the company’s Power Portfolio, DuraPro™ aims to optimize procedural workflows by combining advanced oscillating technology with integrated navigation.

Advancing the High-Speed Drill Market with Next-Generation Oscillation

SHERIDAN, WYOMING – July 22, 2025 – Globus Medical, Inc. (NYSE: GMED), a global leader in musculoskeletal solutions, today announced a significant strategic initiative with the authorization of a share repurchase program of up to $500 million of the company’s outstanding common stock. The move underscores Globus Medical’s confidence in its long-term business fundamentals and commitment to delivering sustained value for shareholders.

Strategic Response to Market Valuation Trends

SHERIDAN, WYOMING – July 21, 2025 – KaVo Dental has launched the DIAGNOcam Vision Full HD, an innovative dental diagnostic device that enables simultaneous capture, presentation, and storage of three diagnostic images in less than one second. Designed to integrate seamlessly into existing clinical workflows, this advanced system supports dental professionals in enhancing diagnostic accuracy while improving patient communication and care.

Revolutionizing Dental Diagnostics with Real-Time Triple Imaging

SHERIDAN, WYOMING – July 21, 2025 – KaVo has introduced the SURGmatic™ S15 L Pro high-speed contra-angle surgical handpiece, positioning itself at the forefront of surgical innovation with a product designed to meet a broad spectrum of clinical demands. Engineered for both surgical and non-surgical applications, the SURGmatic S15 L Pro underscores KaVo’s commitment to performance, reliability, and operator efficiency in demanding clinical environments.

Enhanced Performance for Complex Surgical Applications

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced a new strategic collaboration with Broad Clinical Labs, aiming to accelerate the adoption of its next-generation Sequencing by Expansion (SBX) technology, with an initial focus on trio-based whole genome sequencing for critically ill newborns and their biological parents. The partnership signifies a pivotal move in expanding genomics-enabled healthcare and precision medicine at scale.